Graviola inhibits hypoxia-induced NADPH oxidase activity in prostate cancer cells reducing their proliferation and clonogenicity

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Deep, Gagan ^a,b   Kumar, Rahul ^a   Jain, Anil K ^a   Dhar, Deepanshi ^a   Panigrahi, Gati K ^a   Hussain, Anowar ^a,c   Agarwal, Chapla ^a,b   El Elimat, Tamam ^d   Sica, Vincent P ^d   Oberlies, Nicholas H ^d   Agarwal, Rajesh ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO CANCER CENTER   (United States)

^c TEZPUR UNIVERSITY   (India)

^d UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYBB PROTEIN, MOUSE; MEMBRANE PROTEIN; OXIDOREDUCTASE; PLANT EXTRACT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1;

ADENOCARCINOMA; ANIMAL; ANNONACEAE; CELL HYPOXIA; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; ENZYMOLOGY; HUMAN; MALE; METABOLISM; PROSTATIC NEOPLASMS; TRANSGENIC MOUSE; TUMOR CELL LINE;

ADENOCARCINOMA; ANIMALS; ANNONACEAE; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL HYPOXIA; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MICE, TRANSGENIC; NADH, NADPH OXIDOREDUCTASES; NADPH OXIDASE; PLANT EXTRACTS; PROSTATIC NEOPLASMS;

EID: 84960981664     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep23135     Document Type: Article

References (42)

1. Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2015. CA Cancer J Clin 65, 5-29 (2015).
2. Kumar, B., Koul, S., Khandrika, L., Meacham, R. B. & Koul, H. K. Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype. Cancer Res 68, 1777-1785 (2008).
3. Khandrika, L., Kumar, B., Koul, S., Maroni, P. & Koul, H. K. Oxidative stress in prostate cancer. Cancer Lett 282, 125-136 (2009).
4. Lim, S. D. et al. Increased Nox1 and hydrogen peroxide in prostate cancer. Prostate 62, 200-207 (2005).
5. Arbiser, J. L. et al. Reactive oxygen generated by Nox1 triggers the angiogenic switch. Proc Natl Acad Sci USA 99, 715-720 (2002).
6. Tam, N. N., Gao, Y., Leung, Y. K. & Ho, S. M. Androgenic regulation of oxidative stress in the rat prostate: involvement of NAD(P) H oxidases and antioxidant defense machinery during prostatic involution and regrowth. Am J Pathol 163, 2513-2522 (2003).
7. Block, K. & Gorin, Y. Aiding and abetting roles of NOX oxidases in cellular transformation. Nat Rev Cancer 12, 627-637 (2012).
8. Li, Q. et al. NADPH oxidase subunit p22(phox)-mediated reactive oxygen species contribute to angiogenesis and tumor growth through AKT and ERK1/2 signaling pathways in prostate cancer. Biochim Biophys Acta 1833, 3375-3385 (2013).
9. Lambeth, J. D. Nox enzymes, ROS, and chronic disease: an example of antagonistic pleiotropy. Free Radic Biol Med 43, 332-347 (2007).
10. Kamata, T. Roles of Nox1 and other Nox isoforms in cancer development. Cancer Sci 100, 1382-1388 (2009).
11. Suh, Y. A. et al. Cell transformation by the superoxide-generating oxidase Mox1. Nature 401, 79-82 (1999).
12. Itoh, T. et al. Cisplatin induces production of reactive oxygen species via NADPH oxidase activation in human prostate cancer cells. Free Radic Res 45, 1033-1039 (2011).
13. Suzuki, S. et al. Apocynin, an NADPH oxidase inhibitor, suppresses rat prostate carcinogenesis. Cancer Sci 104, 1711-1717 (2013).
14. Antony, S. et al. Characterization of NADPH oxidase 5 expression in human tumors and tumor cell lines with a novel mouse monoclonal antibody. Free Radic Biol Med 65, 497-508 (2013).
15. Suzuki, S., Pitchakarn, P., Sato, S., Shirai, T. & Takahashi, S. Apocynin, an NADPH oxidase inhibitor, suppresses progression of prostate cancer via Rac1 dephosphorylation. Exp Toxicol Pathol 65, 1035-1041 (2013).
16. Diebold, I., Petry, A., Hess, J. & Gorlach, A. The NADPH oxidase subunit NOX4 is a new target gene of the hypoxia-inducible factor-1. Mol Biol Cell 21, 2087-2096 (2010).
17. Yuan, G. et al. Hypoxia-inducible factor 1 mediates increased expression of NADPH oxidase-2 in response to intermittent hypoxia. J Cell Physiol 226, 2925-2933 (2011).
18. Block, K. et al. NAD(P)H oxidases regulate HIF-2alpha protein expression. J Biol Chem 282, 8019-8026 (2007).
19. Ushio-Fukai, M. & Nakamura, Y. Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy. Cancer Lett 266, 37-52 (2008).
20. Ramteke, A. et al. Exosomes secreted under hypoxia enhance invasiveness and stemness of prostate cancer cells by targeting adherens junction molecules. Mol Carcinog 54, 554-565 (2015).
21. Butterworth, K. T. et al. Hypoxia selects for androgen independent LNCaP cells with a more malignant geno-and phenotype. Int J Cancer 123, 760-768 (2008).
22. Ranasinghe, W. K. et al. The role of hypoxia-inducible factor 1alpha in determining the properties of castrate-resistant prostate cancers. Plos One 8, e54251 (2013).
23. Dai, Y., Bae, K. & Siemann, D. W. Impact of hypoxia on the metastatic potential of human prostate cancer cells. Int J Radiat Oncol Biol Phys 81, 521-528 (2011).
24. Morton, J. Soursop In Fruits of warm climates (ed Morton, J.) 75-80 (Echo Point Books and Media, 1987).
25. Dai, Y. et al. Selective growth inhibition of human breast cancer cells by graviola fruit extract in vitro and in vivo involving downregulation of EGFR expression. Nutr Cancer 63, 795-801 (2011).
26. Torres, M. P. et al. Graviola: a novel promising natural-derived drug that inhibits tumorigenicity and metastasis of pancreatic cancer cells in vitro and in vivo through altering cell metabolism. Cancer Lett 323, 29-40 (2012).
27. Raina, K. et al. Stage-specific inhibitory effects and associated mechanisms of silibinin on tumor progression and metastasis in transgenic adenocarcinoma of the mouse prostate model. Cancer Res 68, 6822-6830 (2008).
28. Raina, K. et al. Dietary feeding of silibinin inhibits prostate tumor growth and progression in transgenic adenocarcinoma of the mouse prostate model. Cancer Res 67, 11083-11091 (2007).
29. Sun, S., Liu, J., Kadouh, H., Sun, X. & Zhou, K. Three new anti-proliferative Annonaceous acetogenins with mono-tetrahydrofuran ring from graviola fruit (Annona muricata). Bioorg Med Chem Lett 24, 2773-2776 (2014).
30. Brar, S. S. et al. NOX5 NAD(P)H oxidase regulates growth and apoptosis in DU 145 prostate cancer cells. Am J Physiol Cell Physiol 285, C353-369 (2003).
31. Le Ven, J. et al. Comprehensive characterization of Annonaceous acetogenins within a complex extract by HPLC-ESI-LTQOrbitrap( R) using post-column lithium infusion. J Mass Spectrom 47, 1500-1509 (2012).
32. Fall, D., Duval, R. A., Gleye, C., Laurens, A. & Hocquemiller, R. Chamuvarinin, an acetogenin bearing a tetrahydropyran ring from the roots of Uvaria chamae. J Nat Prod 67, 1041-1043 (2004).
33. Allegrand, J. et al. Structural study of acetogenins by tandem mass spectrometry under high and low collision energy. Rapid Commun Mass Spectrom 24, 3602-3608 (2010).
34. Maraldi, T. Natural compounds as modulators of NADPH oxidases. Oxid Med Cell Longev 2013, 271602 (2013).
35. Jaquet, V., Scapozza, L., Clark, R. A., Krause, K. H. & Lambeth, J. D. Small-molecule NOX inhibitors: ROS-generating NADPH oxidases as therapeutic targets. Antioxid Redox Signal 11, 2535-2552 (2009).
36. McLaughlin, J. L. Paw paw and cancer: annonaceous acetogenins from discovery to commercial products. J Nat Prod 71, 1311-1321 (2008).
37. Oberlies, N. H., Croy, V. L., Harrison, M. L. & McLaughlin, J. L. The Annonaceous acetogenin bullatacin is cytotoxic against multidrug-resistant human mammary adenocarcinoma cells. Cancer Lett 115, 73-79 (1997).
38. Morre, D. J., de Cabo, R., Farley, C., Oberlies, N. H. & McLaughlin, J. L. Mode of action of bullatacin, a potent antitumor acetogenin: inhibition of NADH oxidase activity of HeLa and HL-60, but not liver, plasma membranes. Life Sci 56, 343-348 (1995).
39. Alali, F. Q., Liu, X. X. & McLaughlin, J. L. Annonaceous acetogenins: recent progress. J Nat Prod 62, 504-540 (1999).
40. El-Elimat, T. et al. Greensporones: resorcylic acid lactones from an aquatic Halenospora sp. J Nat Prod 77, 2088-2098 (2014).
41. Schlaepfer, I. R. et al. Hypoxia induces triglycerides accumulation in prostate cancer cells and extracellular vesicles supporting growth and invasiveness following reoxygenation. Oncotarget 6, 22836-22856 (2015).
42. Deep, G., Inturi, S. & Agarwal, R. Methods to analyze chemopreventive effect of silibinin on prostate cancer biomarkers protein expression In Cancer Prevention: Dietary Factors and Pharmacology (eds Bode, A. & Dong, Z.) 85-105 (Humana Press, 2013).